Online citations, reference lists, and bibliographies.
← Back to Search

Inhibition Of Hypoxia-inducible Factor (HIF) Hydroxylases By Citric Acid Cycle Intermediates

P. Koivunen, Maija Hirsilä, A. Remes, I. Hassinen, K. Kivirikko, J. Myllyharju
Published 2007 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The stability and transcriptional activity of the hypoxia-inducible factors (HIFs) are regulated by two oxygen-dependent events that are catalyzed by three HIF prolyl 4-hydroxylases (HIF-P4Hs) and one HIF asparaginyl hydroxylase (FIH). We have studied possible links between metabolic pathways and HIF hydroxylases by analyzing the abilities of citric acid cycle intermediates to inhibit purified human HIF-P4Hs and FIH. Fumarate and succinate were identified as in vitro inhibitors of all three HIF-P4Hs, fumarate having Ki values of 50–80 μm and succinate 350–460 μm, whereas neither inhibited FIH. Oxaloacetate was an additional inhibitor of all three HIF-P4Hs with Ki values of 400–1000 μm and citrate of HIF-P4H-3, citrate being the most effective inhibitor of FIH with a Ki of 110 μm. Culturing of cells with fumarate diethyl or dimethyl ester, or a high concentration of monoethyl ester, stabilized HIF-1α and increased production of vascular endothelial growth factor and erythropoietin. Similar, although much smaller, changes were found in cultured fibroblasts from a patient with fumarate hydratase (FH) deficiency and upon silencing FH using small interfering RNA. No such effects were seen upon culturing of cells with succinate diethyl or dimethyl ester. As FIH was not inhibited by fumarate, our data indicate that the transcriptional activity of HIF is quite high even when binding of the coactivator p300 is prevented. Our data also support recent suggestions that the increased fumarate and succinate levels present in the FH and succinate dehydrogenase-deficient tumors, respectively, can inhibit the HIF-P4Hs with consequent stabilization of HIF-αs and effects on tumor pathology.
This paper references
10.1016/0076-6879(69)13072-4
[65] Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods
J. Williamson (1969)
10.1111/J.1432-1033.1977.TB11888.X
Mechanism of the prolyl hydroxylase reaction. 1. Role of co-substrates.
L. Tuderman (1977)
10.1111/J.1432-1033.1984.TB07907.X
The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification of distinct subsites and evidence for 2-oxoglutarate decarboxylation in a ligand reaction at the enzyme-bound ferrous ion.
K. Majamaa (1984)
10.1016/s0021-9258(18)48093-3
Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action.
T. Sasaki (1987)
10.1042/BJ2750469
Inhibition of prolyl hydroxylation and procollagen processing in chick-embryo calvaria by a derivative of pyridine-2,4-dicarboxylate. Characterization of the diethyl ester as a proinhibitor.
G. Tschank (1991)
10.1073/PNAS.89.16.7467
Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system.
K. Vuori (1992)
10.1093/emboj/16.6.1173
Characterization of the iron‐ and 2‐oxoglutarate‐binding sites of human prolyl 4‐hydroxylase
J. Myllyharju (1997)
Inhibition of HIF Prolyl 4-Hydroxylases 4532 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME
J. Myllyharju (1997)
10.1007/s004210050074
Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema
V. Pavlíček (2000)
10.1086/324413
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.
A. Gimenez-Roqueplo (2001)
10.1126/SCIENCE.1059796
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation
Panu Jaakkola (2001)
10.1126/SCIENCE.1059817
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing
M. Ivan (2001)
10.1016/S0092-8674(01)00507-4
C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation
A. C. Epstein (2001)
10.1073/pnas.181341498
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F. Yu (2001)
10.1126/SCIENCE.1066373
A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
R. Bruick (2001)
10.1038/ng1019
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Sonny O. Ang (2002)
10.1126/SCIENCE.1068592
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
David Lando (2002)
10.1073/pnas.192342099
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
M. Ivan (2002)
10.1038/ng849
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
I. Tomlinson (2002)
10.1074/JBC.C200273200
Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family*
K. Hewitson (2002)
10.1101/GAD.991402
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.
David Lando (2002)
10.1038/nrc1013
A role for mitochondrial enzymes in inherited neoplasia and beyond
C. Eng (2003)
10.1038/nrc1187
Targeting HIF-1 for cancer therapy
G. Semenza (2003)
10.1016/j.tem.2003.08.004
On the association of succinate dehydrogenase mutations with hereditary paraganglioma
B. Baysal (2003)
10.1016/S0945-053X(03)00006-4
Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis.
J. Myllyharju (2003)
10.1016/S0959-437X(02)00010-2
The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer.
W. Kim (2003)
10.1074/JBC.M304982200
Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor*
M. Hirsilä (2003)
10.1152/AJPRENAL.00252.2002
HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest.
A. M. Devlin (2003)
10.1093/emboj/cdg392
HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia
E. Berra (2003)
10.1038/nrm1366
Oxygen sensing by HIF hydroxylases
C. Schofield (2004)
10.1074/JBC.M312254200
Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases*
P. Koivunen (2004)
10.1096/fj.04-1640fje
Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cells
C. Warnecke (2004)
10.1007/s00109-004-0563-y
A novel mutation of the fumarase gene in a family with autosomal recessive fumarase deficiency
A. Remes (2004)
10.1016/j.febslet.2004.09.005
Determination and comparison of specific activity of the HIF‐prolyl hydroxylases
J. Tuckerman (2004)
10.1007/BF00291651
Progressive muscular dystrophy (Duchenne): Biochemical studies by flow-cytometry
M. Hirsch-Kauffmann (2004)
10.1042/BJ20031647
Endogenous 2-oxoacids differentially regulate expression of oxygen sensors.
C. Dalgard (2004)
10.1074/JBC.M406026200
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor*
R. Appelhoff (2004)
10.1016/J.TIG.2003.11.004
Collagens, modifying enzymes and their mutations in humans, flies and worms.
J. Myllyharju (2004)
10.1093/HMG/DDI227
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
P. Pollard (2005)
10.1146/ANNUREV.BIOCHEM.74.082803.133142
Proline hydroxylation and gene expression.
W. Kaelin (2005)
10.1016/J.CCR.2005.06.017
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.
J. Isaacs (2005)
10.1016/J.CCR.2004.11.022
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
M. Selak (2005)
10.1096/fj.04-3399fje
Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway
M. Hirsilä (2005)
10.1074/jbc.M508718200
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1*
H. Lu (2005)



This paper is referenced by
10.1016/j.jbc.2021.100904
Mitochondrial metabolism regulates macrophage biology
Yafang Wang (2021)
10.1007/s00726-021-03032-5
Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy.
Yating Liu (2021)
10.1186/S43556-020-00012-1
Cancer metabolism and intervention therapy
Huakan Zhao (2021)
10.1016/j.biocel.2021.105982
The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
Mengchao Yu (2021)
10.3390/ijms22115574
From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
Emanuela Di Gregorio (2021)
10.1038/s41467-021-23042-x
EGFR-HIF1α signaling positively regulates the differentiation of IL-9 producing T helper cells
Suyasha Roy (2021)
10.1007/s13402-021-00623-y
The impact of mitochondria on cancer treatment resistance.
M. van der Merwe (2021)
10.1096/fj.202002778R
Targeting alveolar‐specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury
C. Vohwinkel (2021)
10.1007/s11064-021-03454-3
Hypoxia-Inducible Factor-1α (HIF-1α) Inhibition Impairs Retinoic Acid-Induced Differentiation in SH-SY5Y Neuroblastoma Cells, Leading to Reduced Neurite Length and Diminished Gene Expression Related to Cell Differentiation.
Pedro Ozorio Brum (2021)
10.3389/fonc.2021.735077
Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report
Tao Wang (2021)
10.1371/journal.pone.0249103
Crosstalk in oxygen homeostasis networks: SKN-1/NRF inhibits the HIF-1 hypoxia-inducible factor in Caenorhabditis elegans
Dingxia Feng (2021)
10.1016/j.jbc.2021.100397
Development of a colorimetric α-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins
Samantha J. Wong (2021)
10.3892/br.2021.1421
Cocaine potentiates an inflammatory response in C6 astroglia-like cells
Maryam Agharahimi (2021)
10.1007/s12015-020-10111-9
α-Tocopherol Acetate Attenuates Mitochondrial Oxygen Consumption and Maintains Primitive Cells within Mesenchymal Stromal Cell Population.
D. Loncaric (2021)
10.1038/s41584-021-00621-2
The role of HIF proteins in maintaining the metabolic health of the intervertebral disc
Elizabeth S. Silagi (2021)
10.1016/j.canlet.2021.11.024
Succinate receptor 1 inhibits mitochondrial respiration in cancer cells addicted to glutamine.
(2021)
10.1016/j.celrep.2021.108955
The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity.
G. Cavalli (2021)
10.15252/embj.2020106214
BNIP3 promotes HIF‐1α‐driven melanoma growth by curbing intracellular iron homeostasis
Mónica Vara-Pérez (2021)
10.1016/j.freeradbiomed.2021.01.008
The epigenetic and morphogenetic effects of molecular oxygen and its derived reactive species in development.
M. J. Hitchler (2021)
10.1101/2021.11.08.467804
A chemical screen for suppressors of dioxygenase inhibition in a yeast model of familial paraganglioma
William Beimers (2021)
10.3390/life11010069
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Inseo Choi (2021)
10.1111/acel.13291
α‐ketoglutarate delays age‐related fertility decline in mammals
Zhenzhen Zhang (2021)
10.1016/j.celrep.2021.109911
Regulatory T cell differentiation is controlled by αKG-induced alterations in mitochondrial metabolism and lipid homeostasis.
Maria I. Matias (2021)
10.3389/fcvm.2021.709509
Hypoxia Inducible Factors as Central Players in the Pathogenesis and Pathophysiology of Cardiovascular Diseases
Emilio Y. Lucero García Rojas (2021)
10.3389/fcell.2021.629238
Polarization of Macrophages in Insects: Opening Gates for Immuno-Metabolic Research
Adam Bajgar (2021)
10.3389/fimmu.2021.624746
The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming
N. Luque-Campos (2021)
10.3390/biom11091259
Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases
Alexis Paulina Jiménez-Uribe (2021)
10.3390/biom10010093
Redox Signaling from Mitochondria: Signal Propagation and Its Targets
P. Ježek (2020)
10.1089/ten.teb.2019.0283
Hypoxia Inducible Factor-1α in Osteochondral Tissue Engineering
Dheraj K Taheem (2020)
10.1016/j.jtherbio.2020.102691
Heat acclimation mediated cardioprotection is controlled by mitochondrial metabolic remodeling involving HIF-1α.
A. Mreisat (2020)
10.1002/glia.23913
Neuroinflammatory inhibition of synaptic long‐term potentiation requires immunometabolic reprogramming of microglia
E. York (2020)
10.1016/j.ceb.2019.12.005
Structural basis for GPCR signaling by small polar versus large lipid metabolites-discovery of non-metabolite ligands.
Michael Lückmann (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar